Predicting Survival in Patients Receiving Continuous Flow Left Ventricular Assist Devices The HeartMate II Risk Score

被引:250
作者
Cowger, Jennifer [1 ]
Sundareswaran, Kartik [2 ]
Rogers, Joseph G. [3 ]
Park, Soon J. [4 ]
Pagani, Francis D. [1 ]
Bhat, Geetha [5 ]
Jaski, Brian [6 ]
Farrar, David J. [2 ]
Slaughter, Mark S. [7 ]
机构
[1] Univ Michigan Hlth Syst, Ann Arbor, MI USA
[2] Thoratec Corp, Pleasanton, CA USA
[3] Duke Univ, Med Ctr, Durham, NC USA
[4] Mayo Clin, Rochester, MN USA
[5] Advocate Christ Med Ctr, Oak Lawn, IL USA
[6] Sharp Mem Hosp & Rehabil Ctr, San Diego, CA USA
[7] Univ Louisville, Louisville, KY 40292 USA
关键词
heart failure; left ventricular assist device; mortality; risk; DESTINATION THERAPY; CIRCULATORY SUPPORT; SCREENING SCALE; OUTCOMES; FAILURE; MODEL; IMPLANTATION; REGISTRY;
D O I
10.1016/j.jacc.2012.09.055
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
Objectives The aim of this study was to derive and validate a model to predict survival in candidates for HeartMate II (HMII) (Thoratec, Pleasanton, California) left ventricular assist device (LVAD) support. Background LVAD mortality risk prediction is important for candidate selection and communicating expectations to patients and clinicians. With the evolution of LVAD support, prior risk prediction models have become less valid. Methods Patients enrolled into the HMII bridge to transplantation and destination therapy trials (N = 1,122) were randomly divided into derivation (DC) (n = 583) and validation cohorts (VC) (n = 539). Pre-operative candidate predictors of 90-day mortality were examined in the DC with logistic regression, from which the HMII Risk Score (HMRS) was derived. The HMRS was then applied to the VC. Results There were 149 (13%) deaths within 90 days. In the DC, mortality (n = 80) was higher in older patients (odds ratio [OR]: 1.3, 95% confidence interval [CI]: 1.1 to 1.7 per 10 years), those with greater hypoalbuminemia (OR: 0.49, 95% CI: 0.31 to 0.76 per mg/dl of albumin), renal dysfunction (OR: 2.1, 95% CI: 1.4 to 3.2 per mg/dl creatinine), coagulopathy (OR: 3.1, 95% CI: 1.7 to 5.8 per international normalized ratio unit), and in those receiving LVAD support at less experienced centers (OR: 2.2, 95% CI: 1.2 to 4.4 for <15 trial patients). Mortality in the DC low, medium, and high HMRS groups was 4%, 16%, and 29%, respectively (p < 0.001). In the VC, corresponding mortality was 8%, 11%, and 25%, respectively (p < 0.001). HMRS discrimination was good (area under the receiver-operating characteristic curve: 0.71, 95% CI: 0.66 to 0.75). Conclusions The HMRS might be useful for mortality risk stratification in HMII candidates and may serve as an additional tool in the patient selection process. (J Am Coll Cardiol 2013;61:313-21) (C) 2013 by the American College of Cardiology Foundation
引用
收藏
页码:313 / 321
页数:9
相关论文
共 21 条
  • [1] Discordance between patient-predicted and model-predicted life expectancy among ambulatory patients with heart failure
    Allen, Larry A.
    Yager, Jonathan E.
    Funk, Michele Jonsson
    Levy, Wayne C.
    Tulsky, James A.
    Bowers, Margaret T.
    Dodson, Gwen C.
    O'Connor, Christopher M.
    Felker, G. Michael
    [J]. JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION, 2008, 299 (21): : 2533 - 2542
  • [2] Shared Decision Making - The Pinnacle of Patient-Centered Care
    Barry, Michael J.
    Edgman-Levitan, Susan
    [J]. NEW ENGLAND JOURNAL OF MEDICINE, 2012, 366 (09) : 780 - 781
  • [3] Clinical outcomes for continuous-flow left ventricular assist device patients stratified by pre-operative INTERMACS classification
    Boyle, Andrew J.
    Ascheim, Deborah D.
    Russo, Mark J.
    Kormos, Robert L.
    John, Ranjit
    Naka, Yoshifumi
    Gelijns, Annetine C.
    Hong, Kimberly N.
    Teuteberg, Jeffrey J.
    [J]. JOURNAL OF HEART AND LUNG TRANSPLANTATION, 2011, 30 (04) : 402 - 407
  • [4] COMPARING THE AREAS UNDER 2 OR MORE CORRELATED RECEIVER OPERATING CHARACTERISTIC CURVES - A NONPARAMETRIC APPROACH
    DELONG, ER
    DELONG, DM
    CLARKEPEARSON, DI
    [J]. BIOMETRICS, 1988, 44 (03) : 837 - 845
  • [5] INTERMACS database for durable devices for circulatory support: First annual report
    Kirklin, James K.
    Naftel, David C.
    Stevenson, Lynne Warner
    Kormos, Robert L.
    Pagani, Francis D.
    Miller, Marissa A.
    Ulisney, Karen
    Young, James B.
    [J]. JOURNAL OF HEART AND LUNG TRANSPLANTATION, 2008, 27 (10) : 1065 - 1072
  • [6] The Fourth INTERMACS Annual Report: 4,000 implants and counting
    Kirklin, James K.
    Naftel, David C.
    Kormos, Robert L.
    Stevenson, Lynne W.
    Pagani, Francis D.
    Miller, Marissa A.
    Baldwin, J. Timothy
    Young, James B.
    [J]. JOURNAL OF HEART AND LUNG TRANSPLANTATION, 2012, 31 (02) : 117 - 126
  • [7] Outcomes of left ventricular assist device implantation as destination therapy in the post-REMATCH era - Implications for patient selection
    Lietz, Katherine
    Long, James W.
    Kfoury, Abdallah G.
    Slaughter, Mark S.
    Silver, Marc A.
    Milano, Carmelo A.
    Rogers, Joseph G.
    Naka, Yoshifumi
    Mancini, Donna
    Miller, Leslie W.
    [J]. CIRCULATION, 2007, 116 (05) : 497 - 505
  • [8] Impact of Center Volume on Outcomes of Left Ventricular Assist Device Implantation as Destination Therapy Analysis of the Thoratec HeartMate Registry, 1998 to 2005
    Lietz, Katherine
    Long, James W.
    Kfoury, Abdallah G.
    Slaughter, Mark S.
    Silver, Marc A.
    Milano, Carmelo A.
    Rogers, Joseph G.
    Miller, Leslie W.
    Deng, Mario
    Naka, Yoshifumi
    Mancini, Donna
    [J]. CIRCULATION-HEART FAILURE, 2009, 2 (01) : 3 - 10
  • [9] Model for End-Stage Liver Disease Score Predicts Left Ventricular Assist Device Operative Transfusion Requirements, Morbidity, and Mortality
    Matthews, Jennifer C.
    Pagani, Francis D.
    Haft, Jonathan W.
    Koelling, Todd M.
    Naftel, David C.
    Aaronson, Keith D.
    [J]. CIRCULATION, 2010, 121 (02) : 214 - U65
  • [10] Use of a continuous-flow device in patients awaiting heart transplantation
    Miller, Leslie W.
    Pagani, Francis D.
    Russell, Stuart D.
    John, Ranjit
    Boyle, Andrew J.
    Aaronson, Keith D.
    Conte, John V.
    Naka, Yoshifumi
    Mancini, Donna
    Delgado, Reynolds M.
    MacGillivray, Thomas E.
    Farrar, David J.
    Frazier, O. H.
    [J]. NEW ENGLAND JOURNAL OF MEDICINE, 2007, 357 (09) : 885 - 896